CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop a safe, paediatric-friendly formulation of ivermectin to treat neglected tropical diseases in children under 15 kg. By addressing the lack of suitable treatments, it seeks to reduce morbidity and infection rates in vulnerable populations.
Ivermectin is a critical drug for the control and elimination of multiple neglected tropical diseases.
Currently, children weighing under 15kg do not receive treatment with ivermectin due to an absence of safety data and the lack of a suitable paediatric formulation.
Consequently, these children are left untreated.
This results in considerable morbidity at the individual level and a reservoir of infection at the population level.
These issues create a critical barrier to achieving the goals of t…
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Spain, Madrid
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Spain, Barcelona
Type: Research institute
Activity type: Research Organisations
SME: No
Ghana, Kumasi
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
